Cash Flow DNA Chip Research, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-55.00
-246.00
-360.00
-133.00
-171.00
-127.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
50.00
64.00
3.00
34.00
74.00
-149.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
84.00
-140.00
-336.00
-72.00
-76.00
-259.00
Cash Flow from Investing Activities
-61.00
-15.00
-155.00
-58.00
-51.00
-95.00
Cash Flow from Financing Activities
0.00
269.00
278.00
0.00
445.00
-1.00
Net Cash Inflow / Outflow
22.00
113.00
-213.00
-131.00
318.00
-355.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of DNA Chip Research, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-55.386
196.502
-251.00
-128.19%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
50.731
113.119
-63.00
-55.15%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
84.066
316.796
-232.00
-73.46%
Cash Flow from Investing Activities
-61.223
-16.093
-45.00
-280.43%
Cash Flow from Financing Activities
-0.632
27.04
-27.00
-102.34%
Net Cash Inflow / Outflow
22.211
327.743
-305.00
-93.22%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 159.95% vs 58.35% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
84.07
-140.23
159.95%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
